RRC ID 1439
Author Hassan F, Islam S, Mu MM, Ito H, Koide N, Mori I, Yoshida T, Yokochi T.
Title Lipopolysaccharide prevents doxorubicin-induced apoptosis in RAW 264.7 macrophage cells by inhibiting p53 activation.
Journal Mol Cancer Res
Abstract The effect of lipopolysaccharide on doxorubicin-induced cell death was studied by using mouse RAW 264.7 macrophage cells. Pretreatment with lipopolysaccharide at 10 ng/mL prevented doxorubicin-induced cell death and the inhibition was roughly dependent on the concentration of lipopolysaccharide. Posttreatment with lipopolysaccharide for 1 hour also prevented doxorubicin-induced cell death. Lipopolysaccharide inhibited DNA fragmentation and caspase-3 activation in doxorubicin-treated RAW 264.7 cells, suggesting the prevention of doxorubicin-induced apoptosis. Lipopolysaccharide did not significantly inhibit doxorubicin-induced DNA damage detected by single-cell gel electrophoresis (comet) assay. Lipopolysaccharide definitely inhibited the stabilization and nuclear translocation of p53 in doxorubicin-treated RAW 264.7 cells. Lipopolysaccharide, as well as being an inhibitor of p53, abolished doxorubicin-induced apoptosis. Therefore, p53 was suggested to play a pivotal role in the prevention of doxorubicin-induced apoptosis in RAW 264.7 cells by lipopolysaccharide.
Volume 3(7)
Pages 373-9
Published 2005-7-1
DOI 10.1158/1541-7786.MCR-05-0046
PII 3/7/373
PMID 16046548
MeSH Animals Antibiotics, Antineoplastic / adverse effects Antibiotics, Antineoplastic / antagonists & inhibitors* Apoptosis / drug effects* Cell Line DNA Damage / drug effects DNA Fragmentation / drug effects Doxorubicin / adverse effects Doxorubicin / antagonists & inhibitors* Escherichia coli Humans Lipopolysaccharides / pharmacology* Macrophages / cytology Mice Mice, Inbred BALB C Tumor Suppressor Protein p53 / drug effects* Tumor Suppressor Protein p53 / physiology
IF 4.63
Times Cited 28
WOS Category ONCOLOGY CELL BIOLOGY
Resource
Human and Animal Cells RAW 264(RCB0535)